Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthcare Sector Analysis

UpdatedNov 20, 2025
DataAggregated Company Financials
Companies153
  • 7D-3.5%
  • 3M-6.7%
  • 1Y-2.5%
  • YTD-7.2%

Over the last 7 days, the Healthcare industry has dropped 2.6%, driven by Getinge declining 6.1%. However, the industry is down 4.2% over the past year. Earnings are forecast to grow by 30% annually.

Sector Valuation and Performance

Has the Swedish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Nov 2025SEK 583.9bSEK 230.5bSEK 2.9b44.8x200.7x2.5x
Sun, 19 Oct 2025SEK 601.1bSEK 227.1bSEK 6.7b42.6x90x2.6x
Tue, 16 Sep 2025SEK 607.3bSEK 227.0bSEK 6.6b45x92.1x2.7x
Thu, 14 Aug 2025SEK 611.0bSEK 226.8bSEK 6.6b46.8x92.6x2.7x
Sat, 12 Jul 2025SEK 642.1bSEK 226.7bSEK 6.0b44.9x106.7x2.8x
Mon, 09 Jun 2025SEK 630.5bSEK 226.5bSEK 5.8b43.8x107.9x2.8x
Wed, 07 May 2025SEK 595.0bSEK 223.5bSEK 4.9b37x121.1x2.7x
Fri, 04 Apr 2025SEK 556.3bSEK 221.0bSEK 5.4b34.1x103x2.5x
Sun, 02 Mar 2025SEK 587.0bSEK 206.2bSEK 4.2b36.1x140.1x2.8x
Tue, 28 Jan 2025SEK 583.0bSEK 202.7b-SEK 2,675,919,582.6740.6x-217.9x2.9x
Thu, 26 Dec 2024SEK 577.8bSEK 202.8b-SEK 2,503,902,169.1638.4x-230.7x2.8x
Sat, 23 Nov 2024SEK 506.5bSEK 199.8b-SEK 2,658,058,690.1536.2x-190.6x2.5x
Mon, 21 Oct 2024SEK 599.2bSEK 198.9b-SEK 3,204,651,387.2939.4x-187x3x
Wed, 18 Sep 2024SEK 621.5bSEK 200.0b-SEK 2,795,397,479.0041.3x-222.3x3.1x
Fri, 16 Aug 2024SEK 594.5bSEK 200.0b-SEK 2,551,077,034.8441.1x-233x3x
Sun, 14 Jul 2024SEK 585.4bSEK 196.2b-SEK 3,104,678,694.3238.3x-188.5x3x
Tue, 11 Jun 2024SEK 564.1bSEK 195.7b-SEK 3,147,496,847.3936x-179.2x2.9x
Thu, 09 May 2024SEK 545.0bSEK 196.8b-SEK 2,719,308,488.9535.9x-200.4x2.8x
Sat, 06 Apr 2024SEK 521.8bSEK 192.8b-SEK 3,320,827,050.4345.6x-157.1x2.7x
Mon, 04 Mar 2024SEK 512.0bSEK 192.0b-SEK 3,663,022,021.3645.1x-139.8x2.7x
Wed, 31 Jan 2024SEK 695.1bSEK 191.8b-SEK 796,231,363.0049.1x-873x3.6x
Fri, 29 Dec 2023SEK 542.4bSEK 191.0b-SEK 960,823,433.0047.2x-564.5x2.8x
Sun, 26 Nov 2023SEK 501.3bSEK 190.1b-SEK 1,200,469,045.0050.2x-417.6x2.6x
Tue, 24 Oct 2023SEK 424.7bSEK 186.4b-SEK 1,832,666,692.0032.4x-231.7x2.3x
Thu, 21 Sep 2023SEK 461.5bSEK 185.6b-SEK 2,027,819,006.0035.4x-227.6x2.5x
Sat, 19 Aug 2023SEK 457.5bSEK 185.0b-SEK 1,068,478,910.0037.5x-428.1x2.5x
Mon, 17 Jul 2023SEK 465.5bSEK 179.8b-SEK 1,518,021,230.0044.4x-306.7x2.6x
Wed, 14 Jun 2023SEK 520.2bSEK 178.8b-SEK 763,490,619.0045.9x-681.3x2.9x
Fri, 12 May 2023SEK 521.9bSEK 177.0b-SEK 880,521,138.0042.4x-592.8x2.9x
Sun, 09 Apr 2023SEK 504.0bSEK 172.7b-SEK 1,416,903,805.0035.7x-355.7x2.9x
Tue, 07 Mar 2023SEK 492.7bSEK 171.9b-SEK 1,179,948,248.0037.8x-417.5x2.9x
Thu, 02 Feb 2023SEK 509.7bSEK 166.4bSEK 497.0m35.1x1025.6x3.1x
Sat, 31 Dec 2022SEK 476.1bSEK 165.7bSEK 699.5m31.9x680.6x2.9x
Mon, 28 Nov 2022SEK 491.5bSEK 164.9bSEK 807.4m30.9x608.7x3x
Price to Earnings Ratio

608.7x


Total Market Cap: SEK 491.5bTotal Earnings: SEK 807.4mTotal Revenue: SEK 164.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Sector Price to Earnings3Y Average -118.2x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 199x which is higher than its 3-year average PE of -118x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 57% per year over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare sector?

SE Market-4.34%
Healthcare-3.54%
Pharma0.099%
Biotech-1.75%
Healthcare Services-4.09%
Healthtech-4.75%
Life Sciences-4.96%
Medical Equipment-5.70%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 130x.
    • Analysts are expecting annual earnings growth of 20.2%, which is lower than the prior year's growth of 28.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 42% over the next 5 years.
  • However this is lower than its past earnings growth rate of 97% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SANION SanionaSEK 16.9213.4%
+SEK 276.1m		502.1%PE10.9x
SECARE SwedencareSEK 36.302.7%
+SEK 151.8m		-19.9%PE92.2x
STIL StilleSEK 190.008.3%
+SEK 130.3m		-8.2%PE41x
HAMLET B Hamlet BioPharmaSEK 4.2014.3%
+SEK 93.3m		1.4%PS4191x
HNSA Hansa BiopharmaSEK 27.823.2%
+SEK 87.5m		-6.9%PS15.9x

Latest News

IBT B
SEK 57.00
Infant Bacterial Therapeutics
7D
9.6%
1Y
51.6%
SOBI
SEK 332.40
Swedish Orphan Biovitrum
7D
-2.1%
1Y
14.4%

SOBI: Regulatory Approvals And Revised Guidance Will Shape Performance Amid Competition

Narrative Update on Swedish Orphan Biovitrum Analysts have raised their price target for Swedish Orphan Biovitrum from SEK 351.09 to SEK 360.36, citing improved growth forecasts and stronger profit margin expectations. Analyst Commentary Bullish Takeaways Bullish analysts believe that robust revenue growth prospects support a higher valuation for Swedish Orphan Biovitrum.
LIPUM
SEK 14.30
Lipum
7D
30.6%
1Y
-16.4%
HNSA
SEK 27.82
Hansa Biopharma
7D
3.2%
1Y
-6.9%

Hansa Biopharma AB (publ) (STO:HNSA) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Nov 16
Hansa Biopharma AB (publ) (STO:HNSA) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
EKTA B
SEK 42.56
Elekta
7D
-7.4%
1Y
-31.1%

We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt

Nov 15
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
ASKER
SEK 88.88
Asker Healthcare Group
7D
-3.6%
1Y
n/a
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%
MCOV B
SEK 228.00
Medicover
7D
-4.8%
1Y
31.6%

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 13
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
SECT B
SEK 277.60
Sectra
7D
-4.7%
1Y
2.0%
SECARE
SEK 36.30
Swedencare
7D
2.7%
1Y
-19.9%
IMP A SDB
SEK 53.40
Implantica
7D
-7.6%
1Y
43.0%
SANION
SEK 16.92
Saniona
7D
13.4%
1Y
502.1%
STIL
SEK 190.00
Stille
7D
8.3%
1Y
-8.2%

Stille's (STO:STIL) Soft Earnings Are Actually Better Than They Appear

Nov 03
Stille's (STO:STIL) Soft Earnings Are Actually Better Than They Appear
GETI B
SEK 206.60
Getinge
7D
-6.0%
1Y
24.9%
CURAS
DKK 6.00
Curasight
7D
20.5%
1Y
-47.8%
VIMIAN
SEK 29.22
Vimian Group
7D
-5.6%
1Y
-31.8%